ALKERMES | Kontanter Og Tilsvarende



Cash And Equivalent Endring Dato
AbbVie USD 5.52B 1.73B 2024-12
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
ALKERMES USD 291.15M 636.63M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Biogen USD 2.38B 675.8M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Gilead Sciences USD 9.99B 4.95B 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
J&J USD 6.12B 1.28B 2024-12
Malin Corporation EUR 35.7M 6.4M 2024-06
Merck USD 13.24B 1.35B 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
Otsuka Holdings JPY 426.17B 88.94B 2024-12
Pfizer USD 1.04B 49M 2024-12
Regeneron Pharmaceuticals USD 17.91B 15.9B 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



ALKERMES Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.